Our results showing elevated MTHFD2 expression especially in cancer samples derived from patients with a metastatic disease support in general these conclusions associating NAD dependent methylenetetrahydrofolate dehydrogenase activity with transformed and non-differentiated cells. Here, MTHFD2 is linked to metastatic neoplasm.